For subjects with CABP-associated bacteremia , clinical response/cure rates were similar at Day @ ( @ % vs @ % ) , end of therapy ( @ % vs @ % ) , and test of cure ( @ % vs @ % ) for ceftaroline fosamil and ceftriaxone , respectively .